322 related articles for article (PubMed ID: 9679060)
21. The Smad3 linker region contains a transcriptional activation domain.
Wang G; Long J; Matsuura I; He D; Liu F
Biochem J; 2005 Feb; 386(Pt 1):29-34. PubMed ID: 15588252
[TBL] [Abstract][Full Text] [Related]
22. The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways.
Lei S; Dubeykovskiy A; Chakladar A; Wojtukiewicz L; Wang TC
J Biol Chem; 2004 Oct; 279(41):42492-502. PubMed ID: 15292219
[TBL] [Abstract][Full Text] [Related]
23. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
[TBL] [Abstract][Full Text] [Related]
24. p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response.
Pfitzner E; Jähne R; Wissler M; Stoecklin E; Groner B
Mol Endocrinol; 1998 Oct; 12(10):1582-93. PubMed ID: 9773981
[TBL] [Abstract][Full Text] [Related]
25. CREB binding protein is a required coactivator for Smad-dependent, transforming growth factor beta transcriptional responses in endothelial cells.
Topper JN; DiChiara MR; Brown JD; Williams AJ; Falb D; Collins T; Gimbrone MA
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9506-11. PubMed ID: 9689110
[TBL] [Abstract][Full Text] [Related]
26. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
27. Functional cooperation between Smad proteins and activator protein-1 regulates transforming growth factor-beta-mediated induction of endothelin-1 expression.
Rodríguez-Pascual F; Redondo-Horcajo M; Lamas S
Circ Res; 2003 Jun; 92(12):1288-95. PubMed ID: 12764024
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors.
Li C; Zhu NL; Tan RC; Ballard PL; Derynck R; Minoo P
J Biol Chem; 2002 Oct; 277(41):38399-408. PubMed ID: 12161428
[TBL] [Abstract][Full Text] [Related]
29. The Kaposi's sarcoma-associated herpesvirus K-bZIP protein represses transforming growth factor beta signaling through interaction with CREB-binding protein.
Tomita M; Choe J; Tsukazaki T; Mori N
Oncogene; 2004 Oct; 23(50):8272-81. PubMed ID: 15467747
[TBL] [Abstract][Full Text] [Related]
30. Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.
Mori N; Morishita M; Tsukazaki T; Yamamoto N
Int J Cancer; 2003 Jul; 105(5):661-8. PubMed ID: 12740915
[TBL] [Abstract][Full Text] [Related]
31. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.
Fink SP; Mikkola D; Willson JK; Markowitz S
Oncogene; 2003 Mar; 22(9):1317-23. PubMed ID: 12618756
[TBL] [Abstract][Full Text] [Related]
32. E1A inhibits transforming growth factor-beta signaling through binding to Smad proteins.
Nishihara A; Hanai J; Imamura T; Miyazono K; Kawabata M
J Biol Chem; 1999 Oct; 274(40):28716-23. PubMed ID: 10497242
[TBL] [Abstract][Full Text] [Related]
33. The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain.
de Caestecker MP; Yahata T; Wang D; Parks WT; Huang S; Hill CS; Shioda T; Roberts AB; Lechleider RJ
J Biol Chem; 2000 Jan; 275(3):2115-22. PubMed ID: 10636916
[TBL] [Abstract][Full Text] [Related]
34. Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells.
Chen WB; Lenschow W; Tiede K; Fischer JW; Kalthoff H; Ungefroren H
J Biol Chem; 2002 Sep; 277(39):36118-28. PubMed ID: 12140283
[TBL] [Abstract][Full Text] [Related]
35. Regulation of transforming growth factor-beta and bone morphogenetic protein signalling by transcriptional coactivator GCN5.
Kahata K; Hayashi M; Asaka M; Hellman U; Kitagawa H; Yanagisawa J; Kato S; Imamura T; Miyazono K
Genes Cells; 2004 Feb; 9(2):143-51. PubMed ID: 15009097
[TBL] [Abstract][Full Text] [Related]
36. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function.
Zhang Y; Musci T; Derynck R
Curr Biol; 1997 Apr; 7(4):270-6. PubMed ID: 9094310
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneities in the biological and biochemical functions of Smad2 and Smad4 mutants naturally occurring in human lung cancers.
Yanagisawa K; Uchida K; Nagatake M; Masuda A; Sugiyama M; Saito T; Yamaki K; Takahashi T; Osada H
Oncogene; 2000 May; 19(19):2305-11. PubMed ID: 10822381
[TBL] [Abstract][Full Text] [Related]
38. Smad4/DPC4 silencing and hyperactive Ras jointly disrupt transforming growth factor-beta antiproliferative responses in colon cancer cells.
Calonge MJ; Massagué J
J Biol Chem; 1999 Nov; 274(47):33637-43. PubMed ID: 10559252
[TBL] [Abstract][Full Text] [Related]
39. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.
Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ
Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655
[TBL] [Abstract][Full Text] [Related]
40. The steroid receptor co-activator-1 (SRC-1) potentiates TGF-beta/Smad signaling: role of p300/CBP.
Dennler S; Pendaries V; Tacheau C; Costas MA; Mauviel A; Verrecchia F
Oncogene; 2005 Mar; 24(11):1936-45. PubMed ID: 15688032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
